BIOMAT Database Logo BIOMAT Database Logo

Effect of bed time intermediate acting insulin in NIDDM. 1993

V Sheshiah

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V Sheshiah
Effect of bed time intermediate acting insulin in NIDDM subjects refractory to a combination of sulphonylureas and biguanides.
October 1992, The Journal of the Association of Physicians of India,
V Sheshiah
[Premixed insulin and intermediate-acting insulin].
March 2015, Nihon rinsho. Japanese journal of clinical medicine,
V Sheshiah
Absorption of rapid-acting insulin in obese and nonobese NIDDM patients.
July 1995, Diabetes care,
V Sheshiah
The effect of insulin mixtures in type I diabetics: influence of the intermediate acting insulin on the action of short acting insulin.
January 1987, Diabete & metabolisme,
V Sheshiah
Time-action profiles of the intermediate-acting insulin analogue des(64,65)-human proinsulin.
December 1995, Diabete & metabolisme,
V Sheshiah
Intermediate-acting insulin preparations: NPH and lente.
January 1980, Diabetes care,
V Sheshiah
Intermediate acting insulin for type 2 diabetes.
March 1985, Lancet (London, England),
V Sheshiah
A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by long-acting insulin.
August 2004, International journal of dermatology,
V Sheshiah
Intermediate acting versus long acting insulin for type 1 diabetes mellitus.
July 2008, The Cochrane database of systematic reviews,
V Sheshiah
The contribution of intermediate-acting insulin preparations to daytime insulin treatment.
August 1989, Diabetic medicine : a journal of the British Diabetic Association,
Copied contents to your clipboard!